Evidence map›Paper›PMID 37339342›Full record

Trial reportJournal of the International AIDS Society2023

Impart: findings from a prison-based model of HIV assisted partner notification in Indonesia.

Gabriel J Culbert, Judith A Levy, Alana D Steffen, Agung Waluyo, Valerie A Earnshaw, Arie Rahadi

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07103928 (Prison-Based HIV Partner Notification), which is not on this map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07103928 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Prison-Based HIV Partner Notification

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2026 to 2028Enrolled216ConditionsHIVArmsImpart Assisted Partner Notification, Self-Tell Notification
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Gabriel J CulbertPopulation Health Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.ORCID 0000-0003-0788-2635
Judith A LevyHealth Policy & Administration, School of Public Health, University of Illinois Chicago, Chicago, Illinois, USA.
Alana D SteffenPopulation Health Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois, USA.
Agung WaluyoFaculty of Nursing, Universitas Indonesia, Kota Depok, Jawa Barat, Indonesia.
Valerie A EarnshawHuman Development and Family Sciences, College of Education and Human Development, University of Delaware, Newark, Delaware, USA.
Arie RahadiAIDS Research Center, Atma Jaya Catholic University, Jakarta, Indonesia.
University of Illinois Chicago · USAtma Jaya Catholic University of Indonesia · IDChicago Department of Public Health · USUniversity of Delaware · USUniversity of Indonesia · ID

Funding

IMPART: A Provider-Assisted HIV Partner Notification & Testing Intervention for Prisoners in Indonesia.R34MH115779 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CULBERT, GABRIEL JOHN · 2018 to 2020
$655k
NIMH NIH HHS R34 MH115779
6 · The paper itself

Abstract

introductionAssisted partner notification (APN) safely and effectively increases partner awareness of HIV exposure, testing and case identification in community settings. Nonetheless, it has not been specifically developed or evaluated for use in prison settings where people with HIV often are diagnosed and may have difficulty contacting or otherwise notifying partners. We developed Impart, a prison-based APN model, and evaluated its efficacy in Indonesia to increase partner notification and HIV testing.

methodsFrom January 2020 to January 2021, 55 incarcerated men with HIV were recruited as index participants from six jail and prison facilities in Jakarta in a two-group randomized trial comparing the outcomes of self-tell notification (treatment as usual) versus Impart APN in increasing partner notification and HIV testing. Participants voluntarily provided names and contact information for sex and drug-injection partners in the community with whom they had shared possible HIV exposure during the year prior to incarceration. Participants randomized to the self-tell only condition were coached in how to notify their partners by phone, mail or during an in-person visit within 6 weeks. Participants randomized to Impart APN could choose between self-tell notification or anonymous APN by a two-person team consisting of a nurse and outreach worker. We compared the proportion of partners in each group who were notified of exposure by the end of 6 weeks, subsequently tested and HIV diagnosed.

resultsIndex participants (n = 55) selected 117 partners for notification. Compared to self-tell notification, Impart APN resulted in nearly a six-fold increase in the odds of a named partner being notified of HIV exposure. Nearly two thirds of the partners notified through Impart APN (15/24) completed HIV testing within 6 weeks post notification compared to none of those whom participants had self-notified. One-third of the partners (5/15) who completed HIV testing post notification were diagnosed as HIV positive for the first time.

conclusionsVoluntary APN can be successfully implemented with a prison population and within a prison setting despite the many barriers to HIV notification that incarceration presents. Our findings suggest that the Impart model holds considerable promise to increase partner notification, HIV testing and diagnosis among sex and drug-injecting partners of HIV-positive incarcerated men.

Indexed as

HIV InfectionsContact TracingHumansIndonesiaMalePrisonsSexual Partnerscontact tracingHIV testingIndonesiapartner notificationprisonssubstance use

Identifiers

PMID37339342
PMCPMC10281637
OpenAlexW4381432754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.